1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, November 2019

Healthcare Analysis & Statistics, November 2019

1-30 of about 300 reports

Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Menveo

Menveo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenveo (quadrivalent oligosaccharide diphtheria CRM-197 conjugate vaccine; GlaxoSmithKline) is a quadrivalent meningococcal glycoconjugate vaccine that uses CRM-197, a natural mutant of the ...

  • Industries : Therapy, Pathology
  • Countries : United States, European Union
Nimenrix

Nimenrix

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNimenrix (quadrivalent polysaccharide tetanus toxoid conjugate vaccine; Pfizer) is a conjugated polysaccharide vaccine indicated for active immunization to prevent invasive meningococcal disease ...

  • Industries : Therapy, Pathology
  • Countries : European Union, Europe
Menactra

Menactra

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenactra (Sanofi) is a quadrivalent polysaccharide diphtheria toxoid conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria ...

  • Industries : Therapy, Pathology
  • Countries : United States
Trumenba

Trumenba

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTrumenba (Pfizer) is a bivalent recombinant meningococcal serogroup B vaccine indicated for immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup ...

  • Industries : Pathology
  • Countries : United States
Bexsero

Bexsero

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewBexsero (multicomponent meningococcal serogroup B vaccine; GlaxoSmithKline) is a multicomponent meningococcal serogroup B vaccine. It is approved for the prevention of invasive meningococcal ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States, European Union
MenABCW-135Y

MenABCW-135Y

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewGlaxoSmithKline’s MenABCW-135Y is a pentavalent meningococcal conjugate vaccine for the A, B, C, W-135, and Y meningococcal strains. With all of the vaccine’s announced Phase II trials ...

  • Industries : Pathology, Therapy
  • Countries : United States, European Union
2019 Biomedtracker / Datamonitor Healthcare Post-ESMO Report

2019 Biomedtracker / Datamonitor Healthcare Post-ESMO Report

  • $ 4750
  • Industry report
  • October 2019

The Annual European Society for Medical Oncology (ESMO) 2019 Congress was held in Barcelona, Spain from September 27 to October 1, 2019. Conference highlights included new data from PARP inhibitors in ...

  • Industries : Cancer, Pathology
Minimally Invasive Heart Valve Repair and Replacement Devices

Minimally Invasive Heart Valve Repair and Replacement Devices

  • $ 4750
  • Industry report
  • October 2019

OverviewThis comprehensive medical market and technology report provides an overview and in-depth market analysis of the transcatheter heart valve products used in the treatment of heart valve stenosis, ...

  • Industries : Medical Device
  • Countries : World
Drug Delivery: Inhalation Devices

Drug Delivery: Inhalation Devices

  • $ 4750
  • Industry report
  • October 2019

OverviewIn 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

  • Industries : Drug Delivery, Chronic Disease, Pathology
  • Countries : United States, Japan
Diabetes Management: Insulin Pumps Market (2019)

Diabetes Management: Insulin Pumps Market (2019)

  • $ 4750
  • Industry report
  • September 2019

OverviewValued at nearly $3bn in 2018, the Global Insulin Pumps Market is growing at a fast pace—at a compound annual growth rate (CAGR) of approximately 12%—reaching more than $5bn by 2023­.The market ...

  • Industries : Medical Device
  • Countries : World
Global Market for Fracture Fixation Devices

Global Market for Fracture Fixation Devices

  • $ 4750
  • Industry report
  • August 2019

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for fracture fixation devices. Geographic markets covered by this analysis include the US, Japan, ...

  • Industries : Health Services
  • Countries : United States, World, Japan
Identifying High-Growth Medical Technology Markets in SE Asia to 2023

Identifying High-Growth Medical Technology Markets in SE Asia to 2023

  • $ 2995
  • Industry report
  • August 2019

OverviewWhat constitutes a high-growth market? GDP growth? population expanion? Rising per capita health spending? There is no one answer, and all trends and indicators need to be taken into account. Therefore, ...

  • Industries : Healthcare
  • Countries : Asia
Market Spotlight: Gout, Pharma Intelligence

Market Spotlight: Gout, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Gout market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Market Spotlight: Glaucoma, Pharma Intelligence

Market Spotlight: Glaucoma, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

OverviewThis Market Spotlight report covers the Glaucoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, probability of success, patent information, ...

  • Industries : Health Services, Pathology
  • Countries : United States, World
Market Spotlight: Tuberculosis (TB)

Market Spotlight: Tuberculosis (TB)

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Tuberculosis (TB) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • Industries : Pathology
  • Countries : World
Market Spotlight: Endometriosis, Pharma Intelligence

Market Spotlight: Endometriosis, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Endometriosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Atopic Dermatitis

Market Spotlight: Atopic Dermatitis

  • $ 1318
  • Industry report
  • October 2019

Atopic dermatitis (AD), also known as atopic eczema, is a chronic, pruritic, relapsing inflammatory dermatological condition. The condition usually begins during early infancy and childhood, but can persist ...

  • Industries : Pathology
Market Spotlight: Coronary Artery Disease

Market Spotlight: Coronary Artery Disease

  • $ 1318
  • Industry report
  • October 2019

Coronary artery disease (CAD), also called ischemic heart disease, occurs due to the narrowing of coronary arteries that supply oxygen-rich blood to the heart. A waxy substance called plaque builds up ...

  • Industries : Chronic Disease, Pathology
  • Countries : World
Market Spotlight: Amyotrophic Lateral Sclerosis (ALS), Pharma Intelligence

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS), Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

Amyotrophic lateral sclerosis (ALS) is a fatal late-onset neurodegenerative disorder characterized by progressive muscular paralysis. It leads to damage of the upper and lower motor neurons present in ...

  • Industries : Mental Health, Therapy, Pathology
  • Countries : World
Market Spotlight: Myelofibrosis, Pharma Intelligence

Market Spotlight: Myelofibrosis, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

Myelofibrosis is a myeloproliferative neoplasm which can exist as a primary disease known as primary myelofibrosis, or can evolve to post- polycythemia vera (PV) or post-essential thrombocythemia (ET) ...

  • Industries : Pathology
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on